Masimo (MASI) is a Top-Ranked Growth Stock: Should You Buy?

Company Overview - Masimo Corporation, based in Irvine, CA, develops, manufactures, and markets non-invasive monitoring systems [12] - The company operates in two segments: Healthcare revenues account for 66.6% of FY24 revenues, reflecting a 9.4% increase from FY23, while Non-healthcare revenues make up 33.4%, showing a 9.5% decline [12] Investment Potential - Masimo is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of B, indicating a moderate investment outlook [12] - The company is considered a strong candidate for growth investors, with a Growth Style Score of A, forecasting a year-over-year earnings growth of 23% for the current fiscal year [13] - In the last 60 days, three analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.11 to $5.41 per share [13] - Masimo has an average earnings surprise of +12.4%, suggesting a positive trend in earnings performance [13]